title: Murine endothelial cell lines as models of tumor endothelial cells.
abstract: Identification of appropriate models for in vivo and in vitro preclinical testing of inhibitors of tumor angiogenesis and progression is vital to the successful development of anticancer therapeutics. Although the focus is on human molecular targets, most preclinical in vivo efficacy testing occurs in mice. The goal of the current studies was to identify a murine endothelial cell line to model tumor endothelium for studying the antiangiogenic activity of therapeutic compounds in vitro. In situ hybridization was performed on three s.c. grown syngeneic murine tumors (B16 melanoma, Lewis lung carcinoma, and CT26 colon carcinoma) to assess expression of murine homologs of human tumor endothelial cell markers in the vasculature of these tumor models. Seven murine endothelial cell lines were characterized for expression of the murine homologs of recognized endothelial cell surface markers as well as for tumor endothelial cell surface markers. The seven murine endothelial cell lines had similar generation times and five of the seven lines were able to form tubes on Matrigel. Real-time-PCR and flow cytometry analysis were used to evaluate relative mRNA and protein expression of murine homologs of several recognized endothelial cell surface markers in the seven cell lines. The expression of the mRNA for the murine homologs of five tumor endothelial cell surface markers was also evaluated. The 2H11 cell line expressed all five of the tumor endothelial cell surface markers as well as several well-recognized endothelial cells markers. The 2H11 cell line responds to known and novel antiangiogenic agents by inhibition of proliferation and tube formation. These cells can be used in in vitro angiogenesis assays for evaluating the potential antiangiogenic properties and interspecies cross-reactivity of novel compounds.
authors.affiliation: Genzyme Corporation, Framingham, Massachusetts 01701, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Walter-Yohrling
authors.forename: Sharon
authors.initials: S
authors.lastname: Morgenbesser
authors.forename: Cecile
authors.initials: C
authors.lastname: Rouleau
authors.forename: Rebecca
authors.initials: R
authors.lastname: Bagley
authors.forename: Michelle
authors.initials: M
authors.lastname: Callahan
authors.forename: William
authors.initials: W
authors.lastname: Weber
authors.forename: Beverly A
authors.initials: BA
authors.lastname: Teicher
mesh_terms: D000818:Animals; D001483:Base Sequence; D018929:Cell Culture Techniques / Q000379:methods; D002460:Cell Line; D003110:Colonic Neoplasms; D017931:DNA Primers; D004730:Endothelium, Vascular / Q000166:cytology / Q000473:pathology*; D006801:Humans; D017403:In Situ Hybridization; D008175:Lung Neoplasms; D008546:Melanoma, Experimental; D051379:Mice; D008954:Models, Biological; D016133:Polymerase Chain Reaction; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood / Q000235:genetics; D019043:Vascular Neoplasms / Q000473:pathology*
chemical_list: D017931:DNA Primers; D019010:Vascular Cell Adhesion Molecule-1